Found: 307
Select item for more details and to access through your institution.
Perceptions about the efficacy of extended half‐life (EHL) factor products in persons with haemophilia (PWH): A national survey of haemophilia providers from haemophilia treatment centres (HTCs) in the United States.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e780, doi. 10.1111/hae.14427
- By:
- Publication type:
- Article
Immune tolerance induction using Fc‐fusion‐protein recombinant factor IX in severe haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e776, doi. 10.1111/hae.14424
- By:
- Publication type:
- Article
The safety of plasma‐derived haemophilia factor concentrates – comments on "Deep viral metagenomics in patients with haemophilia receiving plasma‐derived coagulation factor concentrates" Nunes Valença I et al. (2021). Deep viral metagenomics in patients with haemophilia receiving plasma‐derived coagulation factor concentrates. Haemophilia. https://doi.org/10.1111/hae.14382
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e760, doi. 10.1111/hae.14400
- Publication type:
- Article
Cover Image.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
- By:
- Publication type:
- Article
Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1002, doi. 10.1111/hae.14435
- By:
- Publication type:
- Article
Single centre, real‐world experience of perioperative rFIXFc use in adult patients with haemophilia B undergoing major and minor surgery.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e690, doi. 10.1111/hae.14426
- By:
- Publication type:
- Article
Thrombomodulin in patients with mild to moderate bleeding tendency.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1028, doi. 10.1111/hae.14433
- By:
- Publication type:
- Article
Real‐world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e698, doi. 10.1111/hae.14432
- By:
- Publication type:
- Article
Clinical and patient reported outcome in total ankle replacement compared to ankle fusion in end‐stage haemophilic arthropathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e739, doi. 10.1111/hae.14429
- By:
- Publication type:
- Article
Increased endoglin levels correlated with angiogenesis‐associated angiopoietin‐2 in haemophilia patients.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e747, doi. 10.1111/hae.14430
- By:
- Publication type:
- Article
Haemophilia diagnostics with modern genomics.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e754, doi. 10.1111/hae.14428
- Publication type:
- Article
Evaluation of the sexual health in people living with hemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 993, doi. 10.1111/hae.14410
- By:
- Publication type:
- Article
All‐cause mortality and causes of death in persons with haemophilia: A systematic review and meta‐analysis.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 897, doi. 10.1111/hae.14423
- By:
- Publication type:
- Article
Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 967, doi. 10.1111/hae.14420
- By:
- Publication type:
- Article
Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1045, doi. 10.1111/hae.14422
- By:
- Publication type:
- Article
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e772, doi. 10.1111/hae.14421
- By:
- Publication type:
- Article
Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1062, doi. 10.1111/hae.14408
- By:
- Publication type:
- Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
- By:
- Publication type:
- Article
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 911, doi. 10.1111/hae.14418
- By:
- Publication type:
- Article
Bleeding with iron deposition and vascular remodelling in subchondral cysts: A newly discovered feature unique to haemophilic arthropathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e730, doi. 10.1111/hae.14417
- By:
- Publication type:
- Article
Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e704, doi. 10.1111/hae.14416
- By:
- Publication type:
- Article
Surgery in mild haemophilia A patients with a history of inhibitor antibodies against factor VIII: Individualized management.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e768, doi. 10.1111/hae.14415
- By:
- Publication type:
- Article
Coordinating physiotherapy care for persons with haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1051, doi. 10.1111/hae.14404
- By:
- Publication type:
- Article
The actual and ideal roles of haemophilia treatment centre social workers in the United States and the barriers to ideal roles.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e683, doi. 10.1111/hae.14414
- By:
- Publication type:
- Article
Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1037, doi. 10.1111/hae.14403
- By:
- Publication type:
- Article
Prophylaxis in children with haemophilia in an evolving treatment landscape.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 889, doi. 10.1111/hae.14412
- By:
- Publication type:
- Article
Haemophilic arthropathy: Contemporary management challenges and a future scenario.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e765, doi. 10.1111/hae.14411
- Publication type:
- Article
Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 957, doi. 10.1111/hae.14401
- By:
- Publication type:
- Article
In response to WFH guidelines for the management of haemophilia, 3<sup>rd</sup> edition: Is there a difference between extended‐half‐life FVIII products or not?
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e762, doi. 10.1111/hae.14407
- By:
- Publication type:
- Article
Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1007, doi. 10.1111/hae.14405
- By:
- Publication type:
- Article
Changes of static and dynamic spine alignment in patients with severe haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e721, doi. 10.1111/hae.14406
- By:
- Publication type:
- Article
Clinical features and genetic defect in six index patients with congenital fibrinogen disorders: Three novel mutations with one common mutation in Taiwan's population.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1022, doi. 10.1111/hae.14399
- By:
- Publication type:
- Article
Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e713, doi. 10.1111/hae.14397
- By:
- Publication type:
- Article
Low immunogenicity of emicizumab in persons with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 984, doi. 10.1111/hae.14398
- By:
- Publication type:
- Article
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 974, doi. 10.1111/hae.14393
- By:
- Publication type:
- Article
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 947, doi. 10.1111/hae.14391
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14058
- Publication type:
- Article
Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e756, doi. 10.1111/hae.14392
- By:
- Publication type:
- Article
Afibrinogenemia with two compound heterozygous mutations in FGA gene.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e641, doi. 10.1111/hae.14377
- By:
- Publication type:
- Article
A qualitative study on the experiences of haemophilia carriers before, during and after pregnancy.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e675, doi. 10.1111/hae.14396
- By:
- Publication type:
- Article
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e667, doi. 10.1111/hae.14395
- By:
- Publication type:
- Article
Clinical attributes and treatment characteristics are associated with work productivity and activity impairment in people with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 938, doi. 10.1111/hae.14302
- By:
- Publication type:
- Article
Identification of F8 rearrangements in carrier and non‐carrier mothers of haemophilia A patients.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e654, doi. 10.1111/hae.14394
- By:
- Publication type:
- Article
Prostate interventions in patients with mild haemophilia: Safe and feasible.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e659, doi. 10.1111/hae.14388
- By:
- Publication type:
- Article
Quality of periprocedural care in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 830, doi. 10.1111/hae.14389
- By:
- Publication type:
- Article
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 932, doi. 10.1111/hae.14381
- By:
- Publication type:
- Article
Validation of the pictorial blood loss assessment chart using modern sanitary products.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e632, doi. 10.1111/hae.14373
- By:
- Publication type:
- Article
Quality of life of people with hereditary factor XIII deficiency treated at a reference centre.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e649, doi. 10.1111/hae.14387
- By:
- Publication type:
- Article
Changes in pain profile of patients with haemophilia during 1‐year follow‐up.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 783, doi. 10.1111/hae.14380
- By:
- Publication type:
- Article
European principles of care for women and girls with inherited bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 837, doi. 10.1111/hae.14379
- By:
- Publication type:
- Article